Propranolol Adjuvant Treatment of Bladder Cancer
Propranolol Adjuvant Treatment of Bladder Cancer: a Randomized Phase II Clinical Trial
Sponsor: Central South University
Listed as NCT04493489, this PHASE2 trial focuses on Bladder Cancer and remains ongoing. Sponsored by Central South University, it has been updated 5 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
5 versions recorded-
Oct 2024 — Present [monthly]
Unknown PHASE2
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2
-
Aug 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Central South University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.